サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1577518

フェムテックの世界市場

FemTech
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
フェムテックの世界市場
出版日: 2024年10月25日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

フェムテックの世界市場は2030年までに1,070億米ドルに達する見込み

2023年に366億米ドルと推定されたフェムテックの世界市場は、2030年には1,070億米ドルに達し、分析期間2023-2030年のCAGRは16.6%で成長すると予測されます。フェムテックデバイスは、本レポートで分析しているセグメントの1つであり、CAGRは16.8％を記録し、分析期間終了時には388億米ドルに達すると予測されています。フェムテックソフトウェア分野の成長率は、分析期間中CAGR 18.1％と推定されます。

米国市場は96億米ドル、中国はCAGR 15.5％で成長すると予測

米国のフェムテック市場は2023年に96億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに163億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは15.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ15.2%と14.2%と予測されています。欧州では、ドイツがCAGR約12.1%で成長すると予測されています。

世界のフェムテック市場- 主要動向と促進要因のまとめ

なぜフェムテックは世界のヘルスケアシーンで大きな牽引力となっているのか？

フェムテックは女性向けテクノロジーの略称で、女性の健康とウェルネスのニーズに応えるテクノロジーとイノベーションに焦点を当て、世界のヘルスケア分野で急成長しています。この市場には、デジタル・ヘルス・ソリューション、ウェアラブル、モバイル・アプリ、診断ツール、リプロダクティブ・ヘルス、妊娠ケア、更年期障害、月経の健康、不妊症、性の健康、一般的な健康などの問題に特に対処する製品などが含まれます。女性特有のヘルスケアニーズに対する認識が高まる中、フェムテックは、これまでヘルスケアイノベーションの中で存在感が薄かったソリューションを提供する重要な存在になりつつあります。

フェムテックの台頭の主な理由の一つは、モバイルテクノロジー、ウェアラブルデバイス、デジタルヘルスプラットフォームへのアクセスなどの進歩に支えられ、女性が自分の健康をコントロールする力が高まっていることです。女性は、月経周期の追跡、生殖能力のモニター、妊娠管理、遠隔医療サービスへのアクセスにますますテクノロジーを利用するようになり、ヘルスケアに関する意思決定についてより大きな自主性を持つようになっています。さらに、更年期障害や月経障害など、多くの女性の健康問題は、従来のヘルスケアプロバイダーによって長い間十分なサービスが提供されておらず、フェムテックソリューションが現在取り組んでいるギャップを残しています。このような女性特有の生物学的ニーズに対応した個別化ヘルスケアソリューションに対する需要の急増が、フェムテックの急成長を後押ししています。

さらに、男女平等への社会的なシフトと女性の健康問題への関心の高まりが、この市場への注目度を高めています。公衆衛生キャンペーン、指導的地位に女性が占める割合の増加、女性起業家の台頭などが、女性向けの革新的なヘルスケアソリューションの推進に寄与しています。政府、ヘルスケア・プロバイダー、投資家が、女性の健康により効果的に取り組むことの経済的・社会的利益を認識するにつれ、フェムテックは世界中で大きな支持を集め、より包括的なヘルスケア・テクノロジーへの道を開いています。

技術の進歩はフェムテックソリューションをどのように強化していますか？

技術の進歩は、女性の健康ソリューションの機能性、アクセシビリティ、パーソナライゼーションを向上させ、フェムテックに革命をもたらしています。フェムテックにおける最も重要なイノベーションのひとつは、女性が生殖に関する様々な側面を追跡・管理できるモバイルヘルス（mヘルス）アプリの台頭です。Clue、Flo、Natural Cyclesのようなアプリは、ユーザーが月経周期をモニターし、排卵を予測し、症状を追跡することを可能にし、生殖能力と健康全般に関する洞察を提供します。これらのアプリは、人工知能（AI）と機械学習アルゴリズムを使用してデータを分析し、パーソナライズされた推奨事項を提供することで、女性が自分独自の健康パターンを理解しやすくしています。さらに、これらのデジタル・プラットフォームは、女性に合わせた健康に関する洞察を提供することで、避妊、不妊治療、一般的な健康について、十分な情報に基づいた意思決定をする力を与えます。

ウェアラブル・テクノロジーは、フェムテックにおけるもう一つの主要な進歩分野です。スマートブレスレットやパッチなどのウェアラブルデバイスには、バイタルサイン、ホルモンレベル、女性の健康に関連するその他の生理学的指標をモニターするセンサーが搭載されています。例えば、Avaのようなウェアラブル端末は、生理学的データを利用して受胎可能期間を追跡し、女性が受胎計画を管理するための非侵襲的な方法を提供しています。これらのデバイスは、ホルモンの変動、ストレスレベル、さらには睡眠パターンなど、生殖や健康全般に直接影響を与える要素をリアルタイムで監視できるバイオセンシング技術の進歩により、より洗練されたものになってきています。ウェアラブルとスマートフォンアプリの統合も、包括的な健康追跡と分析のためのデータ同期によってユーザー体験を向上させる。

遠隔医療と遠隔ヘルスケアサービスの進歩は、フェムテック市場をさらに拡大しています。バーチャル・ヘルスケア・プラットフォームにより、特に妊産婦ケア、性の健康、更年期管理などの分野で、女性が医療相談にアクセスしやすくなっています。女性の健康に特化した遠隔医療サービスは、患者が直接診療所を訪れることなく、専門家のアドバイスや処方箋、治療オプションを受けられる便利な方法を提供します。このアクセスのしやすさは、専門的ヘルスケアへのアクセスが制限されている可能性のある、地方や十分なサービスを受けていない地域に住む女性にとって特に価値があります。遠隔医療やAIを活用した診断の台頭により、フェムテックは、より便利で個別化され、すぐに利用できるようにすることで、女性のケアの質を向上させています。

消費者の嗜好の変化や社会の動向は、フェムテック市場をどのように形成していますか？

消費者の嗜好の変化や社会の動向は、世界のフェムテック市場を形成する上で重要な役割を果たしています。特に、より多くの女性が個別化された、便利で利用しやすいヘルスケアソリューションを求めています。この動向の主要な推進力のひとつは、セルフケアと予防医療への関心の高まりです。女性は健康管理に対してより積極的になり、心身の健康を追跡、理解、改善できるツールを求めています。不妊治療追跡アプリ、生理管理ツール、更年期障害サポート機器などのフェムテックソリューションは、従来のヘルスケアプロバイダーだけに頼ることなく、女性特有のニーズを管理できるようにカスタマイズされたヘルスケアオプションを提供することで、この動向に合致しています。

性別特有のヘルスケア課題に対する意識の高まりは、消費者の行動にも影響を与えています。何十年もの間、月経障害、子宮内膜症、更年期障害といった女性の健康問題は、過小診断か過小調査のどちらかでした。ヘルスケア・サービスにおけるこのギャップが、女性のニーズに特化した専門的ソリューションの需要につながっています。消費者は、ホルモンモニタリング用ウェアラブルから骨盤底筋トレーナーまで、これらの問題に対する真の解決策を提供する製品やサービスを求めており、フェムテックイノベーションの新たな道が開かれました。こうした動向は、スマートケーゲルトレーナーや性的健康教育を提供するアプリなど、性的健康の管理に役立つ製品に対する需要にも反映されており、これらはすべて、より包括的な女性の健康管理に貢献しています。

ヘルスケアを含むあらゆる分野での男女平等と代表権を求める社会の動きも、フェムテック市場を形成する重要な動向です。女性起業家、イノベーター、ヘルスケア専門家は、女性の健康に対応する製品やサービスの開発を主導しており、こうしたニーズがより広範なヘルスケアシステムの中で優先されることを確実にしています。また、投資家がこの市場の未開拓の可能性と収益性を認識しているため、フェムテック新興企業へのベンチャーキャピタルからの投資も増えています。さらに、リプロダクティブ・ライツ（性と生殖に関する権利）、ヘルスケアにおけるジェンダーの平等、女性の健康問題の汚名返上といった議論により、フェムテック企業は知名度を上げ、製品をより効果的に販売しやすくなっています。

さらに、デジタル・プラットフォームとソーシャルメディアの台頭により、フェムテック企業は消費者と直接関わることができるようになり、ヘルスケアに対するコミュニティ主導のアプローチを生み出しています。多くのフェムテックブランドは、月経、不妊、更年期障害など、これまでタブーとされてきたトピックを取り上げ、女性の健康について教育し、力を与えるためにソーシャルメディアを使っています。企業と消費者の間のこのオープンな対話は、女性が自分の健康ニーズについてより気軽に話し合い、自分に合った解決策を求める、より包括的な環境を作り出しています。このような消費者の嗜好の変化は、男女平等や透明性を求める社会の動向と相まって、フェムテック市場の成長を促進し、女性によりパーソナライズされたヘルスケア体験を生み出しています。

フェムテックの世界市場成長の原動力は？

世界のフェムテック市場の成長は、女性の健康ソリューションへの投資の増加、技術革新、パーソナライズされたヘルスケアに対する消費者の需要の高まりなど、いくつかの重要な要因によって牽引されています。この成長の主な促進要因の一つは、フェムテックの大きな市場可能性を認識しているベンチャーキャピタルやヘルスケア投資家からの注目と資金調達の増加です。歴史的に、女性の健康はヘルスケア・イノベーションにおいて資金不足であり、代表的な存在ではありませんでしたが、近年、業界が専門的な製品やサービスの必要性を認識するにつれ、投資が急増しています。リプロダクティブ・ヘルス、妊産婦ケア、更年期管理に特化したフェムテック新興企業は大きな牽引力を得ており、最先端の製品を開発し市場でのプレゼンスを拡大するために、数社が大規模な資金を確保しています。

成長のもう一つの大きな原動力は、女性の健康問題に対する意識の拡大と予防医療へのシフトです。ウェアラブル・テクノロジーとmヘルス・アプリの台頭により、女性は月経周期の追跡、生殖能力のモニタリング、慢性疾患の管理をリアルタイムで行うことで、自分の健康を管理できるようになってきています。これらのテクノロジーは、女性が十分な情報に基づいたヘルスケアの決断を下し、必要なときに早期の介入を求める力を与え、従来のヘルスケア・システムの負担を軽減し、長期的な健康成果を促進します。予防医療ソリューション、特に不妊管理や妊娠ケアなどの分野に対する需要は、フェムテック市場のさらなる拡大を促進すると予想されます。

女性の健康状態の改善に対する世界の関心の高まりも、フェムテックの採用を促進する上で重要な役割を果たしています。世界中の政府やヘルスケア機関は、リプロダクティブヘルスケアへのアクセス改善から、より良い妊産婦ケアサービスの提供まで、女性の健康課題への対処を目的としたイニシアチブを開始しています。これは、ヘルスケアへのアクセスが限られている発展途上地域で特に顕著であり、フェムテックソリューションは、女性ヘルスケアにおけるギャップを埋める効率的な方法を提供します。遠隔医療、教育リソース、健康追跡ツールへのアクセスを提供するモバイルヘルスプラットフォームは、こうした地域では特に価値が高く、市場の成長を促進し、健康の公平性を向上させます。

最後に、ウェルネスと個別化ヘルスケアを求める社会動向は、フェムテック市場の成長に大きく寄与しています。消費者がセルフケアとパーソナライズされた健康ソリューションをますます優先するようになるにつれて、フェムテック製品はあらゆる年代の女性にとってウェルネス・ルーティンの重要な構成要素になりつつあります。フェムテックは、不妊治療追跡デバイスやアプリからホルモンモニター用ウェアラブル、骨盤の健康ソリューションまで、リアルタイムなインサイトとカスタマイズされたケアを提供する製品を提供し、女性が自分の健康状態を管理しやすくしています。パーソナライズされたハイテク主導のヘルスケアに対する需要の高まりは、フェムテックの技術革新と投資を促し、世界市場での継続的な成長を位置づけています。

投資の増加、技術の進歩、予防的で個別化されたケアに対する消費者の需要の高まり、女性の健康状態の改善に対する世界の関心の高まりが相まって、フェムテックの世界市場は急速に拡大しています。ヘルスケア産業が女性の健康を優先し、長年のケア格差に対処し続ける中、フェムテックは世界中の女性のヘルスケアの未来を変える重要な役割を担っています。

調査対象企業の例（全 39件）

  • Aavia
  • Allara Health
  • Athena Feminine Technologies, Inc.
  • BioWink GmbH（Clue）
  • Bloomlife
  • Canopie Inc.
  • Coroflo Limited
  • Flo Health
  • Glow Inc.
  • LunaJoy

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP24365

Global FemTech Market to Reach US$107.0 Billion by 2030

The global market for FemTech estimated at US$36.6 Billion in the year 2023, is expected to reach US$107.0 Billion by 2030, growing at a CAGR of 16.6% over the analysis period 2023-2030. FemTech Devices, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$38.8 Billion by the end of the analysis period. Growth in the FemTech Software segment is estimated at 18.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.6 Billion While China is Forecast to Grow at 15.5% CAGR

The FemTech market in the U.S. is estimated at US$9.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$16.3 Billion by the year 2030 trailing a CAGR of 15.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.2% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.

Global FemTech Market – Key Trends & Drivers Summarized

Why Is FemTech Gaining Major Traction in the Global Healthcare Landscape?

FemTech, short for female technology, has emerged as a rapidly growing segment in the global healthcare landscape, focusing on technology and innovations that cater to women’s health and wellness needs. This market includes digital health solutions, wearables, mobile apps, diagnostic tools, and products that specifically address issues such as reproductive health, pregnancy care, menopause, menstrual health, fertility, sexual health, and general wellness. With increasing awareness of women’s unique healthcare needs, FemTech is becoming a critical player in providing solutions that have been historically underrepresented in healthcare innovation.

One of the key reasons for the rise of FemTech is the increasing empowerment of women to take control of their health, supported by advancements in mobile technology, wearable devices, and access to digital health platforms. Women are increasingly turning to technology to track menstrual cycles, monitor fertility, manage pregnancy, and access telemedicine services, giving them greater autonomy over their healthcare decisions. Additionally, many women’s health issues, such as menopause or menstrual disorders, have long been underserved by traditional healthcare providers, leaving a gap that FemTech solutions are now addressing. This surge in demand for personalized healthcare solutions that cater to women’s unique biological needs is driving the rapid growth of FemTech.

Furthermore, societal shifts toward gender equality and increased focus on women’s health issues have brought more attention to this market. Public health campaigns, greater representation of women in leadership positions, and the rise of women entrepreneurs have all contributed to the push for more innovative healthcare solutions for women. As governments, healthcare providers, and investors recognize the economic and social benefits of addressing women’s health more effectively, FemTech is gaining significant traction worldwide, paving the way for more inclusive healthcare technologies.

How Are Technological Advancements Enhancing FemTech Solutions?

Technological advancements are revolutionizing FemTech by improving the functionality, accessibility, and personalization of women’s health solutions. One of the most significant innovations in FemTech has been the rise of mobile health (mHealth) apps that allow women to track and manage various aspects of their reproductive health. Apps like Clue, Flo, and Natural Cycles enable users to monitor their menstrual cycles, predict ovulation, and track symptoms, offering insights into fertility and overall health. These apps use artificial intelligence (AI) and machine learning algorithms to analyze data and provide personalized recommendations, making it easier for women to understand their unique health patterns. Additionally, these digital platforms empower women to make informed decisions about contraception, fertility treatments, and general health by providing them with tailored health insights.

Wearable technology is another major area of advancement within FemTech. Wearable devices, such as smart bracelets and patches, now come equipped with sensors that monitor vital signs, hormone levels, and other physiological metrics related to women’s health. For example, wearables like Ava use physiological data to track fertility windows, offering non-invasive ways for women to manage fertility planning. These devices are becoming more sophisticated, with advancements in biosensing technologies that allow for real-time monitoring of hormone fluctuations, stress levels, and even sleep patterns—factors that directly impact reproductive and overall health. The integration of wearables with smartphone apps also enhances user experience by syncing data for comprehensive health tracking and analysis.

Advances in telemedicine and remote healthcare services are further expanding the FemTech market. Virtual healthcare platforms are making it easier for women to access medical consultations, especially in areas such as prenatal care, sexual health, and menopause management. Telemedicine services that specialize in women’s health offer a convenient way for patients to receive expert advice, prescriptions, and treatment options without needing to visit a clinic in person. This accessibility is particularly valuable for women living in rural or underserved areas, where access to specialized healthcare may be limited. With the rise of telemedicine and AI-powered diagnostics, FemTech is improving the quality of care for women by making it more convenient, personalized, and readily available.

How Are Changing Consumer Preferences and Societal Trends Shaping the FemTech Market?

Changing consumer preferences and societal trends are playing a crucial role in shaping the global FemTech market, particularly as more women demand personalized, convenient, and accessible healthcare solutions. One of the key drivers of this trend is the increasing focus on self-care and preventive health. Women are becoming more proactive about managing their health, seeking tools that enable them to track, understand, and improve their physical and mental well-being. FemTech solutions, such as fertility tracking apps, period management tools, and menopause support devices, align with this trend by offering customized healthcare options that help women manage their unique needs without relying solely on traditional healthcare providers.

The increasing awareness of gender-specific healthcare challenges is also influencing consumer behavior. For decades, women's health issues, such as menstrual disorders, endometriosis, and menopause, were either underdiagnosed or under-researched. This gap in healthcare services has led to a demand for specialized solutions that cater specifically to women's needs. Consumers are seeking products and services that provide real solutions to these issues, from hormone-monitoring wearables to pelvic floor trainers, which have opened up new avenues for FemTech innovation. These trends are also reflected in the demand for products that help manage sexual health, such as smart Kegel trainers or apps that provide sexual health education, all of which contribute to more comprehensive women’s health management.

The societal push for gender equality and representation in all sectors, including healthcare, is another important trend shaping the FemTech market. Women entrepreneurs, innovators, and healthcare professionals are leading the charge in developing products and services that cater to women’s health, ensuring that these needs are prioritized within the broader healthcare system. This has also resulted in more venture capital investment into FemTech startups, as investors recognize the untapped potential and profitability of the market. Additionally, discussions around reproductive rights, gender parity in healthcare, and the destigmatization of women’s health issues have made it easier for FemTech companies to gain visibility and market their products more effectively.

Moreover, the rise of digital platforms and social media has enabled FemTech companies to engage directly with consumers, creating a community-driven approach to healthcare. Many FemTech brands use social media to educate and empower women about their health, addressing topics that have historically been considered taboo, such as menstruation, fertility, and menopause. This open dialogue between companies and consumers is creating a more inclusive environment, where women feel more comfortable discussing their health needs and seeking solutions tailored specifically for them. These changing consumer preferences, coupled with societal trends toward gender equality and transparency, are driving growth in the FemTech market and creating a more personalized healthcare experience for women.

What Is Driving the Growth of the Global FemTech Market?

The growth of the global FemTech market is being driven by several key factors, including increased investment in women’s health solutions, technological innovation, and rising consumer demand for personalized healthcare. One of the primary drivers of this growth is the increasing attention and funding from venture capitalists and healthcare investors who recognize the significant market potential in FemTech. Historically, women’s health has been underfunded and underrepresented in healthcare innovation, but recent years have seen a surge in investment as the industry acknowledges the need for specialized products and services. FemTech startups focusing on reproductive health, maternal care, and menopause management have gained substantial traction, with several companies securing large rounds of funding to develop cutting-edge products and expand their market presence.

Another significant driver of growth is the expanding awareness of women’s health issues and the shift toward preventive care. With the rise of wearable technology and mHealth apps, women are increasingly able to take control of their health by tracking their menstrual cycles, monitoring fertility, and managing chronic conditions in real time. These technologies empower women to make informed healthcare decisions and seek early interventions when needed, reducing the burden on traditional healthcare systems and promoting long-term health outcomes. The demand for preventive health solutions, particularly in areas like fertility management and pregnancy care, is expected to drive further expansion of the FemTech market.

The growing global focus on improving women’s health outcomes is also playing a key role in driving FemTech adoption. Governments and healthcare organizations worldwide are launching initiatives aimed at addressing women’s health challenges, from improving access to reproductive healthcare to providing better maternal care services. This is particularly evident in developing regions where access to healthcare is limited, and FemTech solutions offer an efficient way to bridge the gap in women’s healthcare. Mobile health platforms that provide access to telemedicine, educational resources, and health tracking tools are particularly valuable in these areas, driving market growth and improving health equity.

Lastly, societal trends toward wellness and personalized healthcare are significantly contributing to the growth of the FemTech market. As consumers increasingly prioritize self-care and personalized health solutions, FemTech products are becoming a key component of wellness routines for women of all ages. From fertility tracking devices and apps to hormone-monitoring wearables and pelvic health solutions, FemTech offers products that provide real-time insights and customized care, making it easier for women to manage their health on their own terms. This rising demand for personalized and tech-driven healthcare is encouraging innovation and investment in FemTech, positioning it for continued growth in the global market.

The combination of increased investment, technological advancements, growing consumer demand for preventive and personalized care, and a global focus on improving women’s health outcomes is driving the rapid expansion of the global FemTech market. As the healthcare industry continues to prioritize women's health and address long-standing gaps in care, FemTech is poised to play a pivotal role in transforming the future of healthcare for women worldwide.

Select Competitors (Total 39 Featured) -

  • Aavia
  • Allara Health
  • Athena Feminine Technologies, Inc.
  • BioWink GmbH (Clue)
  • Bloomlife
  • Canopie Inc.
  • Coroflo Limited
  • Flo Health
  • Glow Inc.
  • LunaJoy

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • FemTech - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Womens Health and Wellness Propels Growth in FemTech Market
    • Case Overview: Growth in Digital Health Platforms Fuels Adoption of FemTech Solutions
    • Technological Innovations in Fertility Tracking and Reproductive Health Strengthen Business Case for FemTech
    • Focus on Menstrual Health and Hormonal Wellness Drives Market Adoption of FemTech Apps
    • Increasing Investments in Women-Centric Startups Expands Opportunities for FemTech Innovations
    • Case Overview: Rising Popularity of Telemedicine and Virtual Healthcare Bodes Well for FemTech Market Growth
    • Focus on Maternal and Prenatal Care Strengthens Market Adoption of FemTech Solutions
    • Focus on Sexual Health and Wellness Drives Innovation in FemTech Products and Services
    • Increasing Use of FemTech for Mental Health and Wellbeing Strengthens Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World FemTech Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for FemTech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for FemTech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for FemTech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Consumer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Consumer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Consumer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Direct-to-Consumer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Direct-to-Consumer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Direct-to-Consumer End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Fertility Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for FemTech by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for FemTech by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for FemTech by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION